ArticleAging and disease2025
New Insight into the Mechanism of Neurochemical Imbalance in Multiple Sclerosis: Abnormal Transportation of Brain Extracellular Space.
Article in Aging and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Brain Extracellular Space: From an Overlooked Dimension to Catalyst of a Novel Neuroscience Paradigm.Cyborg and bionic systems (Washington, D.C.) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurochemical imbalance is a contributing factor to neurological symptoms in multiple sclerosis (MS). The matured myelin sheath is crucial for substance transportation within the extracellular space (ECS) and for maintaining local homeostasis. Therefore, we hypothesize that disturbed ECS transportation following demyelinating lesions might lead to neurochemical imbalance in MS. In the current study, a lysophosphatidylcholine-induced unilateral MS model was used to investigate spatial neurochemical alterations. The results demonstrated that 168 substances were altered around the demyelination site in the ipsilateral hemisphere, compared to the contralateral hemisphere, with significant enrichment in the purine and arginine-proline metabolic pathways. Notably, dopamine was unexpectedly detected in the demyelinated region and the adjacent thalamus. Tracer-based MRI further revealed that the tracer injected into the striatum abnormally refluxed to the thalamus, with the area of reflux consistent with the altered dopamine distribution. The interstitial fluid drained extensively but was confined to the unilateral hemisphere, which may explain the observed widespread changes in other neuroactive substances. Importantly, after the restoration of ECS integrity, both interstitial fluid drainage and neurochemical imbalance, including dopamine, were normalized, supporting the potential link between ECS dysfunction and neurochemical imbalance. These observations highlight the crucial role of ECS transport in maintaining neurochemical homeostasis in the brain, providing new insights into the mechanisms that may underline the neuropsychiatric symptoms of MS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.